
CellTrans
Chicago, IL, United States celltransinc.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
CellTrans develops and manufactures cellular therapies and bioengineered technologies for diabetes and other endocrine disorders. It provides clinical islet isolation and transplantation services, pre-clinical transplant research, and in-vitro islet assay services. The company operates from Chicago, Illinois, with a research lab and a cell isolation facility at University Hospital.
Services
Clinical Services
Manufactures high-quality human islets for clinical transplantation, including FDA-approved Lantidra (donislecel-jujn) and autologous islet transplants.
Pre-Clinical Services
Provides contract research from proof of concept through IND/IDE-enabling pre-clinical testing for islets and islet-like biologics.
In-Vitro Services
Performs in vitro islet assays and microfluidic assessments to evaluate islet physiology, viability, purity, and function.
Assays & in vitro testing
Consultations
Offers consultation services through the company contact and staff listed on the site.
Capabilities
- Assays and studies
- Rodent models · Non-human primate · Cell therapy · In vivo · Multiparametric Microfluidic Assay · Microfluidic Oxygen Consumption Rate In Response To Glucose · Morphology Assessment with Islet Scoring · Viability Assessment · Purity Assessment · Static Glucose Stimulated Insulin Secretion (GSIS) Assay · Identity · Endotoxin Quantification
2 more
Potency · Sterility - Scale and capacity
- Fully Certified ISO 7 and ISO 5 processing areas · Over 1,000 sq. ft of support space · Three rooms of ISO 14644 classified space covering 800 sq. ft. · 1,050 sq. ft. of support space · Two quality control laboratories
- Therapeutic areas
- Diabetes · Type 1 diabetes · Chronic pancreatitis · Endocrine disorders
Instruments and platforms
- Bac-T/ALERT 3D Microbial Detection System
- Insulin ELISA
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human · Xeno · Rodent · Non-human primate · Macaques · Immune-competent mice
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacture of human pancreatic islet cells (LANTIDRA)
Company
- Type
- CRO
- Founded
- 2009
- Ownership
- Small business, as registered with SAM.gov or stated on their site
Locations
- Address
- 2201 W. Campbell Park Dr. Chicago, IL 60612
- Sites
- Chicago, United States
Public records
- FDA drug establishment registration
- 3019202665 · API MANUFACTURE source
Similar labs
Work here? Claim this listing